Creative Medical Technology Holdings, Inc. Banking Regulation, Total Risk-Based Capital, Excess, Actual
Creative Medical Technology Holdings, Inc. (CELZ) had Banking Regulation, Total Risk-Based Capital, Excess, Actual of $154.18 thousand as of 2011-06-30, per its 10-Q/A filed 2011-08-25.
Discontinued › Notes › Banking and Thrift
us-gaap:ExcessCapital · last filed 2011-08-25
- 2011-06-30: Banking Regulation, Total Risk-Based Capital, Excess, Actual $154.18K.
- 2010-12-31: Banking Regulation, Total Risk-Based Capital, Excess, Actual $154.18K.
| Period end | Banking Regulation, Total Risk-Based Capital, Excess, Actual |
|---|---|
| 2011-06-30 | $154.18K 10-Q/A · filed 2011-08-25 |
| 2010-12-31 | $154.18K 10-Q/A · filed 2011-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |